A carregar...
Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
The immunomodulatory agent, lenalidomide, is a structural analogue of thalidomide approved by the US Food and Drug Administration for the treatment of myelodysplastic syndrome (MDS) and multiple myeloma (MM). This agent is also currently under active investigation for the treatment of chronic lympho...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3409527/ https://ncbi.nlm.nih.gov/pubmed/22888354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/513702 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|